Literature DB >> 10369313

Familial paroxysmal dystonic choreoathetosis: clinical findings in a large Japanese family and genetic linkage to 2q.

H Matsuo1, K Kamakura, M Saito, M Okano, T Nagase, Y Tadano, K Kaida, A Hirata, N Miyamoto, T Masaki, R Nakamura, K Motoyoshi, H Tanaka, S Tsuji.   

Abstract

BACKGROUND: Paroxysmal dystonic choreoathetosis (PDC) is a rare familial movement disorder that has been mapped to chromosome 2q31-36.
OBJECTIVE: To study the first Japanese family with PDC clinically and genetically. PATIENTS AND METHODS: We studied a large Japanese family in which at least 17 members in 6 generations have been affected by PDC. We interviewed and examined 26 family members, 8 of whom revealed choreoathetosis-like and dystonialike involuntary movement and 1 of whom revealed no involuntary movement but only muscle stiffness such as the aura of paroxysmal dystonic choreoathetosis (PDC). Genetic linkage studies of this family were carried out with polymorphic DNA markers.
RESULTS: The attacks of involuntary movement or muscle stiffness were precipitated by ovulation, menstruation, emotional stress, or caffeine or alcohol ingestion. Magnetic resonance imaging of the brain revealed no abnormalities. Clonazepam therapy was effective for reducing the attacks, and ingestion of garlic was believed by patients to be effective for softening the attacks. An affected woman with only muscle stiffness showed remission after hysterectomy for hysteromyoma. This woman also had the disease haplotype and transferred it to her typical PDC-affected daughter. Maximal pairwise logarithm of odds scores exceeding 2.00 were obtained at D2S2250, D2S1242, D2S377, D2S2148, and D2S126. The PDC gene was demonstrated by linkage analyses to be located in a 15.3-centimorgan interval lying between D2S371 and D2S339 based on pairwise and multipoint logarithm of odds scores and obligate recombination events in affected individuals.
CONCLUSIONS: Linkage of PDC to chromosome 2q32-36 was confirmed in a Japanese family. The clinical characterizations of this family with PDC include that ovulation seems also to be a precipitating factor of the attacks and that hysterectomy seems to be effective for softening the attacks. Although low-dose clonazepam treatment was most effective, garlic use was believed by affected members to be effective for softening the attacks. Furthermore, based on the results of clinical and genetic analyses, we suggest that muscle stiffness without involuntary movement may represent a forme fruste of PDC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369313     DOI: 10.1001/archneur.56.6.721

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  9 in total

1.  Diagnosis and treatment of paroxysmal dyskinesias revisited.

Authors:  Iris Unterberger; Eugen Trinka
Journal:  Ther Adv Neurol Disord       Date:  2008-09       Impact factor: 6.570

2.  Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia.

Authors:  A Richter; M Hamann
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

3.  Paroxysmal non-kinesigenic dyskinesia, post-streptococcal syndromes and psychogenic movement disorders: a diagnostic challenge.

Authors:  Elena Peila; Paolo Mortara; Alessandro Cicerale; Lorenzo Pinessi
Journal:  BMJ Case Rep       Date:  2015-03-20

4.  Paroxysmal Dyskinesia.

Authors:  Paul S. Fishman
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

5.  Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.

Authors:  Hirotaka Matsuo; Toshinori Chiba; Shushi Nagamori; Akiyoshi Nakayama; Hideharu Domoto; Kanokporn Phetdee; Pattama Wiriyasermkul; Yuichi Kikuchi; Takashi Oda; Junichiro Nishiyama; Takahiro Nakamura; Yuji Morimoto; Keiko Kamakura; Yutaka Sakurai; Shigeaki Nonoyama; Yoshikatsu Kanai; Nariyoshi Shinomiya
Journal:  Am J Hum Genet       Date:  2008-11-20       Impact factor: 11.025

6.  Common variant of leucine-rich repeat-containing 16A (LRRC16A) gene is associated with gout susceptibility.

Authors:  Masayuki Sakiyama; Hirotaka Matsuo; Seiko Shimizu; Toshinori Chiba; Akiyoshi Nakayama; Yuzo Takada; Takahiro Nakamura; Tappei Takada; Emi Morita; Mariko Naito; Kenji Wakai; Hiroki Inoue; Seishiro Tatsukawa; Junki Sato; Kazumi Shimono; Toshiaki Makino; Takahiro Satoh; Hiroshi Suzuki; Yoshikatsu Kanai; Nobuyuki Hamajima; Yutaka Sakurai; Kimiyoshi Ichida; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Hum Cell       Date:  2013-12-07       Impact factor: 4.174

7.  ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout.

Authors:  Hirotaka Matsuo; Hiroyuki Tomiyama; Wataru Satake; Toshinori Chiba; Hiroyuki Onoue; Yusuke Kawamura; Akiyoshi Nakayama; Seiko Shimizu; Masayuki Sakiyama; Manabu Funayama; Kenya Nishioka; Toru Shimizu; Kenichi Kaida; Keiko Kamakura; Tatsushi Toda; Nobutaka Hattori; Nariyoshi Shinomiya
Journal:  Ann Clin Transl Neurol       Date:  2015-01-19       Impact factor: 4.511

8.  Common dysfunctional variants in ABCG2 are a major cause of early-onset gout.

Authors:  Hirotaka Matsuo; Kimiyoshi Ichida; Tappei Takada; Akiyoshi Nakayama; Hiroshi Nakashima; Takahiro Nakamura; Yusuke Kawamura; Yuzo Takada; Ken Yamamoto; Hiroki Inoue; Yuji Oikawa; Mariko Naito; Asahi Hishida; Kenji Wakai; Chisa Okada; Seiko Shimizu; Masayuki Sakiyama; Toshinori Chiba; Hiraku Ogata; Kazuki Niwa; Makoto Hosoyamada; Atsuyoshi Mori; Nobuyuki Hamajima; Hiroshi Suzuki; Yoshikatsu Kanai; Yutaka Sakurai; Tatsuo Hosoya; Toru Shimizu; Nariyoshi Shinomiya
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

9.  Common variants of a urate-associated gene LRP2 are not associated with gout susceptibility.

Authors:  Akiyoshi Nakayama; Hirotaka Matsuo; Toru Shimizu; Yuzo Takada; Takahiro Nakamura; Seiko Shimizu; Toshinori Chiba; Masayuki Sakiyama; Mariko Naito; Emi Morita; Kimiyoshi Ichida; Nariyoshi Shinomiya
Journal:  Rheumatol Int       Date:  2013-12-24       Impact factor: 2.631

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.